2089 Response to chemotherapy allows to identify mCRC patients most likely to benefit from maintenance immunotherapy: A post-hoc analysis from the IMPACT study
Scheithauer, W, Riera-Knorrenschild, J, Kopp, H.G, Mayer, F, Kroening, H, Nitsche, D, Kuhlmann, J, Ziebermayr, R, Andel, J, Arnold, D, Zurlo, A, Wittig, B, Schmoll, H.J
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
6149 POSTER Preliminary Results of a Phase 2-3 Clinical Study With the Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma (IMPACT Study)
Schmidt, M, Schmoll, H.J, Ghiringhelli, F, Mayer, F, Kröning, H, Ziebermayr, R, Schroff, M, Weith, E, Tschaika, M, Wittig, B
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial
Schmoll, H, Wittig, BW, Arnold, DA, Riera-Knorrenschild, JRK, Nietsche, DN, Kroening, HK, Mayer, FM, Andel, JA, Ziebermayr, RZ, Scheithauer, WS
Published in Journal for immunotherapy of cancer (12.03.2014)
Published in Journal for immunotherapy of cancer (12.03.2014)
Get full text
Journal Article
Impact Study: a Subgroup of Metastatic Colorectal Cancer Patients with Very Prolonged Disease Control Under Maintenance Therapy with the Tlr-9 Agonist Mgn1703
Scheithauer, W., Riera-Knorrenschild, J., Kopp, H., Mayer, F., Nitsche, D., Kuhlmann, J., Ziebermayr, R., Andel, J., Arnold, D., Schmidt, M., Schmoll, H.J.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
1061PIMPACT STUDY: A SUBGROUP OF METASTATIC COLORECTAL CANCER PATIENTS WITH VERY PROLONGED DISEASE CONTROL UNDER MAINTENANCE THERAPY WITH THE TLR-9 AGONIST MGN1703
Scheithauer, W., Riera-Knorrenschild, J., Kopp, H., Mayer, F., Nitsche, D., Kuhlmann, J., Ziebermayr, R., Andel, J., Arnold, D., Schmidt, M., Schmoll, H.J.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
A Subgroup of Metastatic Colorectal Cancer Patients with Very Prolonged Disease Control Under Maintenance Therapy with the TLR-9 Agonist MGN1703
Riera-Knorrenschild, J., Kopp, H.G., Mayer, F., Nitsche, D., Kuhlmann, J., Ziebermayr, R., Andel, J., Arnold, D., Schmidt, M., Scheithauer, W., Schmoll, H.J.
Published in Annals of oncology (01.06.2014)
Published in Annals of oncology (01.06.2014)
Get full text
Journal Article
Preliminary results of a phase II/III clinical study of the TLR9 agonist MGN1703 in patients with advanced colorectal carcinoma with disease control after first-line therapy: IMPACT study
Schmidt, M., Schmoll, H., Mayer, F., Riera, J., Hapke, G., Andel, J., Nitsche, D., Ziebermayr, R., Weith, E., Schroff, M., Tschaika, M., Wittig, B.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Fulvestrant (F) as first-line palliative treatment for hormone receptor (HR)- positive metastatic breast cancer
Bartsch, R., Wenzel, C., Ziebermayr, R., Bago-Horvath, Z., Pluschnig, U., Dubsky, P. C., Rudas, M., Gnant, M., Zielinski, C., Steger, G. G.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article